Table 2.

Baseline characteristics of patients included in the meta-analysis

CharacteristicABO-IncompatiblePatients (Studies)ABO-CompatiblePatients (Studies)
Follow-up, mo371346 (26)404943 (26)
Age471346 (26)454943 (26)
Donor age48940 (22)494029 (22)
Total HLA mismatch3.61208 (23)3.14083 (23)
PRA “any prespecified,” %15783 (13)152499 (13)
Donor-specific antibody, %4689 (10)42312 (10)
Retransplantation, %101004 (17)103592 (17)
Pre-emptive, %27999 (18)284138 (17)
Living-related, %47255 (6)62a593 (6)
  • HLA, human leukocyte antigen; PRA, panel-reactive antibody.

  • a P<0.001.